CLYM
Climb Bio, Inc.
Latest Form 4:Sale$407KbyBrennan Aoife (President and CEO) · filed Jun 30, 2026
Climb Bio, Inc. (CLYM) has 5 SEC Form 4 filings (10 transaction rows) in the rolling window, disclosed by 3 distinct insiders. Most recent filing: Jun 30, 2026.
The most active filer is Director Thomas Stephen Basil with 4 filings. Insiders have net sold $1.3M over the trailing 6 months.
- Industry:Biotechnology
- CEO:Aoife Brennan BCh MMSc
- Employees:17
- HQ:Wellesley Hills, DE, US
- IPO:2021-08-10
Insider Buying
$780K
reported purchases (SEC code P)
Insider Selling
$1.3M
reported sales (SEC code S)
Unique Insiders
3
in the rolling window
Market Cap
$836.8M
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
Brennan AoifeFirst filing | President and CEO | Sale | 30,902 | $407K | Jun 30 | SEC ↗ |
| Director | Sale | 33,687 | $236K | Feb 27 | SEC ↗ | |
| Director | Sale | 16,313 | $114K | Feb 27 | SEC ↗ | |
Thomas Stephen BasilFirst filing | Director | Sale | 90,000 | $471K | Feb 17 | SEC ↗ |
Thomas Stephen BasilFirst filing | Director | Sale | 10,000 | $58K | Feb 17 | SEC ↗ |
| Director, 10% Owner | Purchase | 7,111 | $25K | Jan 7 | SEC ↗ | |
| Director, 10% Owner | Purchase | 213,099 | $465K | Dec 15 | SEC ↗ | |
| Director, 10% Owner | Purchase | 101,462 | $290K | Dec 15 | SEC ↗ |
Related companies
Climb Bio, Inc. is in the Healthcare sector.